Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health services and systems news

Show

From To
Egypt targets hepatitis C patients for medical tourism

In mid 2016, Prime Pharma, a private Egyptian pharmaceutical company, launched Tour n’ Cure to revive therapeutic tourism in Egypt. The first target is hepatitis C patients from around the world. Countries targeted are Spain, Belgium, Italy, Netherlands and the UK.

Published
24 February 2017
From
International Medical Tourism Journal
Women at the centre: WHO issues new guidance on the sexual and reproductive health and rights of women living with HIV

A woman-centred approach to healthcare is one that consciously adopts the perspectives of women, their families and communities. This means that health services see women as active participants in, as well as beneficiaries of, trusted health systems that respond to women’s needs, rights and preferences in humane and holistic ways.

Published
23 February 2017
From
World Health Organization
How to Keep HIV Cure-Related Trials Ethical: The Benefit/Risk Ratio Challenge

While high or unknown risks are a mainstay of early-phase trials in areas like cancer research, cure study participants typically have a safe and efficacious alternative to those risks: remaining on antiretrovirals. Can we justify asking patients who are doing well on antiretrovirals to accept the risk and uncertainty of many HIV cure-related trials? If we cannot, we might need to give up on the hope of curing HIV, or of achieving controlled remission.

Published
22 February 2017
From
BMJ Blogs
Messi visits Egypt to promote Hepatitis C treatment

Supported by the Egyptian ministries of tourism and aviation, Prime Pharma started a campaign titled “Tour n’ Cure” to promote tourism treatment in Egypt, with Messi being chosen as ambassador for the campaign worldwide.

Published
22 February 2017
From
Daily News Egypt
Deal reduces price of life-saving hepatitis C drugs for Canadians

Tens of thousands of Canadian patients with mild versions of chronic hepatitis C could soon receive public funding for medications that cure the infection now that the provinces have sealed a deal with three pharmaceutical companies to reduce the cost of the ultra-expensive drugs.

Published
22 February 2017
From
The Globe and Mail
Accelerated linkage to HIV care improves retention in care by a third

Close to 60% of adults benefiting from point-of-care CD4 cell count testing at HIV testing sites, accelerated antiretroviral therapy (ART) initiation and SMS appointment reminders were retained

Published
21 February 2017
By
Carole Leach-Lemens
Better depression care could improve outcomes for HIV treatment programmes

Improved management of depression and other mental health disorders has the potential to improve the outcomes of HIV treatment programmes, Pamela Collins of the National Institute of

Published
21 February 2017
By
Roger Pebody
Peer navigators improve linkage to HIV care and retention in care in South African study

Adults recently diagnosed with HIV getting help from peers to address personal barriers to care together with SMS check-in messages, appointment and healthy living reminders

Published
21 February 2017
By
Carole Leach-Lemens
Integrating ART postnatally improves outcomes for mothers, children

Integration of ART into maternal and child health services during the postnatal period leads to significant improvements in women’s participation in HIV care and resulting viral suppression, according to findings presented at the Conference on Retroviruses and Opportunistic Infections (CROI).

Published
21 February 2017
From
Healio
How Mike Pence used Obamacare to halt Indiana's HIV outbreak

Two years later, the vice president is helping lead the Republican effort to dismantle the program.

Published
21 February 2017
From
Politico
← First12345...596Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.